| Blueprint ID | Learning Objectives |
| 1138 | Interpret critical clinical and laboratory findings which were key in the processes of exclusion, differentiation, and diagnosis. |
| 11001 | Demonstrate appropriate attitudes of empathy, ethics, responsibility and cultural awareness in keeping with the role of a physician. |
| 11002 | Develop strategies to identify reversible causes of acute and chronic heart failure |
| 11003 | Establish effective evidence based treatments including dietary, pharmaceutical and interventional for congestive heart failure |
| 11004 | Establish an appropriate long-term management plan for congestive heart failure |
| 11005 | Determine how treatment should be modified by co-morbidities for congestive heart failure |
| 11006 | Differentiate between symptom relief and mortality reduction as a goal of therapy for congestive heart failure |
| 11007 | Describe the etiology, pathology, and pathophysiology of the major valvular lesions. |
| 11008 | Identify the relevant clinical history, physical findings, and appropriate investigations for valvular heart disease. |
| 11009 | Discuss the management, both medical and surgical, of the valve diseases. |
| 11010 | Identify the etiology of chest pain in the acute setting with reference to (a) key features of history, (b) cardiac markers diagnostic, (c) ECG changes |
| 11011 | Triage acute chest pain |
| 11012 | Apply evidence-based therapies for coronary syndromes |
| 11013 | Identify factors important in determining balance of risk/benefit of non-invasive and invasive treatment strategies for coronary syndromes |
| 11014 | Develop competence to evaluate chest pain with ST elevation within the context of (a) history, (b) ECG changes |
| 11015 | Apply thrombolytic therapy decisions in the context of (a) absolute/relative contraindications, (b) role of timing to benefit of treatment, (c) alternate therapy of primary PCI |
| 11016 | Identify and apply risk reducing adjunctive therapies for acutely, and in the longer term |
| 11017 | Identify features of chest pain that suggest stable symptoms |
| 11018 | Identify the role of history and stress testing in risk stratification of individuals with stable angina |
| 11019 | Identify risk/benefit balance for invasive therapy with respect to factors including renal function/age/COPD/CHF/arrhythmia/DM |
| 11020 | Identify differences in choices based on goals of symptom relief versus mortality benefits |
| 11021 | Review secondary prevention of sudden cardiac death and associated evidence for treatment strategies |
| 11022 | Describe current Canadian Cardiovascular Society guidelines for ICD implantation in this population |
| 11023 | Identify common causes of atrial fibrillation |
| 11024 | Identify the key investigators for new onset atrial fibrillation. |
| 11025 | Apply management strategies with respect to: (a) Antithrombotic treatment strategies and embolic risk assessment. (b) Safety issues with acute cardioversion. (c) Factors leading to rhythm control versus rate control. (d) Successful rate control. |
| 11026 | Identify causal conditions of chest pain or discomfort: (a) central: cardiovascular (ischemic and non-ischemic), pulmonary/mediastinal (pulmonary embolus, tracheitis, and mediastinal malignancy), other (gastrointestinal and neuro-psychiatric), (b) peripheral: chest wall pain, pulmonary |
| 11027 | Outline modifications of risk factors. |
| 11028 | Determine site, description, provoking factors, and radiation of chest pain. |
| 11029 | Differentiate between the following: (a) cardiac pain and other types of visceral pain, (b) visceral chest discomfort and superficial chest discomfort, (c) myocardial infarction from angina |
| 11030 | Obtain vital signs and examine heart and lungs; palpate chest wall and examine abdomen. |
| 11031 | Conduct an effective initial plan of management for a patient with chest pain/discomfort. |
| 11032 | Identify the causal conditions of dyspnea: (a) cardiac causes (myocardial dysfunction, valvular heart disease, deconditioning, pericardial disease, increased cardiac output), (b) pulmonary causes (respiratory control, ventilatory pump, gas exchanger), (c) other (anemia, anxiety, carbon monoxide) |
| 11033 | Differentiate causes of cardiac pulmonary edema. |
| 11034 | Differentiate causes of pulmonary disease. |
| 11035 | Diagnose acute, life-threatening dyspnea in the pediatric or adult patient. |
| 11036 | Conduct an effective management plan for a patient with dyspnea. |
| 11037 | Outline the causal conditions of coronary artery disease: (a) central (cardiovascular, pulmonary/mediastinal, other), (b) peripheral (chest wall pain, pulmonary) |
| 11038 | Differentiate between visceral chest discomfort and superficial chest discomfort. |
| 11039 | Identify patients with myocardial infarction and differentiate from other potentially lethal causes of chest pain. |
| 11040 | Conduct an effective initial plan of management for a patient with coronary artery disease. |
| 11041 | Explain how congestive heart failure is manifested as a pleural effusion. |
| 11042 | Discuss the relationship between acute/chronic dyspnea and congestive heart failure. |
| 11043 | Identify chronic cough as a symptom of congestive heart failure. |
| 11044 | Conduct an examination of the thorax and demonstrate how to detect a pleural effusion. |
| 11045 | Develop a management plan for a patient with congestive heart failure. |
| 11046 | Describe the causal conditions leading to thromboembolism: (a) inherited thrombophilia (Factor V Leiden mutation, antithrombin deficiency; defects in protein S, C, antithrombin; other rare disorders), (b) acquired disorders (malignancy; surgery, trauma; pregnancy, oral contraceptives, hormone replacement, tamoxifen; immobilization, congestive heart failure, heparin therapy; hyperhomocysteinemia; hyperviscosity; other) |
| 11047 | Identify the causal conditions of pulmonary embolism: (a) venous insuffiency (post-phlebitic syndrome or deep venous thrombosis), (b) trauma (muscle strain, tear, twisting injury to extremity, hematoma), (c) lymphedema (primary or secondary), (d) Baker cyst, (e) infection/inflammation (cellulitis/soft tissue/bone; chronic dermatitis/cutaneous mucinosis), (f) infiltrative dermopathy |
| 11048 | Elicit history of risk factors for deep vein thrombosis. |
| 11049 | Determine the severity of the thrombotic condition and the presence of any acquired causes of hypercoagulability. |
| 11050 | Select patients requiring screening for hereditary thrombophilia. |
| 11051 | Examine extremities for superficial and deep vein thrombosis, skin necrosis, livedo reticularis. (a) Examine chest, heart, abdomen for ascites and hepatomegaly, rectal exam, pelvic in women. |
| 11052 | Conduct a management plan for a patient with local edema or a tendency to venous clotting. |
| |